Pages that link to "Q38549333"
Jump to navigation
Jump to search
The following pages link to Claudia Maria Hattinger (Q38549333):
Displaying 50 items.
- Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33 (Q23924183) (← links)
- Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types (Q24170413) (← links)
- Targeting CDKs with Roscovitine Increases Sensitivity to DNA Damaging Drugs of Human Osteosarcoma Cells (Q28554501) (← links)
- Genome-wide association study identifies two susceptibility loci for osteosarcoma (Q28659642) (← links)
- Nucleotide excision repair gene variants and association with survival in osteosarcoma patients treated with neoadjuvant chemotherapy. (Q33985880) (← links)
- A Genome-Wide Scan Identifies Variants in NFIB Associated with Metastasis in Patients with Osteosarcoma (Q36029709) (← links)
- Preclinical validation of Aurora kinases-targeting drugs in osteosarcoma (Q37323073) (← links)
- Candidate germline polymorphisms of genes belonging to the pathways of four drugs used in osteosarcoma standard chemotherapy associated with risk, survival and toxicity in non-metastatic high-grade osteosarcoma (Q37641721) (← links)
- CD99 polymorphisms significantly influence the probability to develop Ewing sarcoma in earlier age and patient disease progression (Q37718471) (← links)
- Emerging drugs for high-grade osteosarcoma (Q37778400) (← links)
- Sensitive mRNA detection by fluorescence in situ hybridization using horseradish peroxidase-labeled oligodeoxynucleotides and tyramide signal amplification. (Q38332459) (← links)
- Advances in emerging drugs for osteosarcoma (Q38506118) (← links)
- Role of pharmacogenetics of drug-metabolizing enzymes in treating osteosarcoma (Q38533459) (← links)
- Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma (Q38734066) (← links)
- Doxorubicin-resistant osteosarcoma: novel therapeutic approaches in sight? (Q38759270) (← links)
- H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance (Q38775062) (← links)
- Pharmacogenomics of second-line drugs used for treatment of unresponsive or relapsed osteosarcoma patients. (Q38791215) (← links)
- Pharmacogenomics of genes involved in antifolate drug response and toxicity in osteosarcoma (Q38809116) (← links)
- The pharmacogenomics of osteosarcoma (Q38848413) (← links)
- Targeting polo-like kinase 1 by NMS-P937 in osteosarcoma cell lines inhibits tumor cell growth and partially overcomes drug resistance (Q38959358) (← links)
- Mechanisms of gene amplification and evidence of coamplification in drug-resistant human osteosarcoma cell lines. (Q39902204) (← links)
- P53 oncosuppressor influences selection of genomic imbalances in response to ionizing radiations in human osteosarcoma cell line SAOS-2. (Q39956747) (← links)
- Clinical impact of the methotrexate resistance-associated genes C-MYC and dihydrofolate reductase (DHFR) in high-grade osteosarcoma. (Q39995579) (← links)
- The molecular mechanisms responsible for resistance to ET-743 (Trabectidin; Yondelis) in the Ewing's sarcoma cell line, TC-71. (Q40354019) (← links)
- 4-Demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548): a promising new candidate for chemotherapeutic treatment of osteosarcoma patients. (Q40378150) (← links)
- Prognostic and therapeutic relevance of HER2 expression in osteosarcoma and Ewing's sarcoma (Q40417879) (← links)
- Analysis of dihydrofolate reductase and reduced folate carrier gene status in relation to methotrexate resistance in osteosarcoma cells (Q40606723) (← links)
- Induction of p21 mRNA synthesis after short-wavelength UV light visualized in individual cells by RNA FISH. (Q40762557) (← links)
- Neuroblastoma cells can actively eliminate supernumerary MYCN gene copies by micronucleus formation--sign of tumour cell revertance? (Q42817425) (← links)
- Genomic imbalances associated with methotrexate resistance in human osteosarcoma cell lines detected by comparative genomic hybridization-based techniques. (Q44634672) (← links)
- Array comparative genomic hybridization reveals frequent alterations of G1/S checkpoint genes in undifferentiated pleomorphic sarcoma of bone (Q45125767) (← links)
- Overcoming glutathione S-transferase P1-related cisplatin resistance in osteosarcoma (Q46431085) (← links)
- Genome-wide association study identifies the GLDC/IL33 locus associated with survival of osteosarcoma patients (Q46904091) (← links)
- Effect of TP53 Arg72Pro and MDM2 SNP309 polymorphisms on the risk of high-grade osteosarcoma development and survival (Q47773300) (← links)
- Prognostic impact of deletions at 1p36 and numerical aberrations in Ewing tumors (Q50756853) (← links)
- Unequivocal identification of disseminated tumor cells in the bone marrow by combining immunological and genetic approaches--functional and prognostic information (Q50758832) (← links)
- Molecular Cytogenetics in Ewing Tumors: Diagnostic and Prognostic Information (Q50759345) (← links)
- Fine-mapping of cytogenetically undetectable EWS/ERG fusions on DNA fibers of Ewing tumors (Q50786318) (← links)
- The EWS protein is dispensable for Ewing tumor growth. (Q50786382) (← links)
- Quality assessment of genetic markers used for therapy stratification. (Q51024497) (← links)
- Targeting glutathione-S transferase enzymes in musculoskeletal sarcomas: a promising therapeutic strategy. (Q53240644) (← links)
- Excision repair cross-complementation group 1 protein expression predicts survival in patients with high-grade, non-metastatic osteosarcoma treated with neoadjuvant chemotherapy. (Q53641041) (← links)
- Targeting ABCB1 and ABCC1 with their Specific Inhibitor CBT-1® can Overcome Drug Resistance in Osteosarcoma. (Q53810147) (← links)
- Frequent deletion of CDKN2A and recurrent coamplification of KIT, PDGFRA, and KDR in fibrosarcoma of bone--an array comparative genomic hybridization study. (Q54712822) (← links)
- Polymorphisms of genes related to metotrexate response and toxicity in high-grade osteosarcoma (Q56961996) (← links)
- Genomic imbalances associated with secondary acute leukemias in Hodgkin lymphoma (Q56994162) (← links)
- Molecular alterations of monophasic synovial sarcoma: loss of chromosome 3p does not alter RASSF1 and MLH1 transcriptional activity (Q56998662) (← links)
- Genetic analysis of fibrosarcoma of bone, a rare tumour entity closely related to osteosarcoma and malignant fibrous histiocytoma of bone (Q57001391) (← links)
- Genetic testing for high-grade osteosarcoma: a guide for future tailored treatments? (Q57457283) (← links)
- Peripheral primitive neuroectodermal tumour of the cervix (Q57756552) (← links)